SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is seeing intense volatility and massive sell-off pressure following federal indictments against company executives for an alleged multi-billion dollar scheme to smuggle controlled hardware to prohibited regions. The community is deeply divided, with many calling for a total management overhaul or anticipating further delisting risks, while others view the depressed valuation as a potential long-term buying opportunity if the company can resolve its severe reputational and legal overhang.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is seeing intense investor activity driven by a significant 47% increase in proved reserves and rising demand for European natural gas security amid ongoing geopolitical volatility in the Middle East. Community sentiment is highly bullish, with many traders focused on the stock's low float and the potential for explosive momentum as participants monitor supply shortages and limited share availability.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing heightened chatter as retail traders debate the potential for future supply-reduction measures and the impact of broader market volatility on meme tokens. Community discussions are heavily split between long-term holders expressing confidence in the asset's utility and vocal skeptics labeling the token a stagnant or failing project.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

The Defiance Daily Target 2X Long SMCI ETF (SMCX) is currently experiencing extreme volatility and massive sell-offs following an indictment of Super Micro Computer's co-founder and others regarding alleged chip export violations to China. The community is actively debating the risks of holding highly leveraged funds, with many retail investors expressing significant financial losses and discussing the mechanics of decay, potential for delisting, and the intense market pressure weighing on the stock.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic is currently seeing intense investor scrutiny and volatility as the market reacts to a downward revision in production guidance alongside ongoing concerns regarding agricultural input costs and global fertilizer supply chain dynamics. Community sentiment remains polarized, with many retail investors viewing the recent pullbacks as a strategic buying opportunity due to the company's dividend yield and long-term role in critical mineral security, while others remain skeptical, citing persistent margin compression and broader sector headwinds.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is currently a focal point for investors as the company makes significant strides toward deep-sea mining permits, buoyed by recent NOAA compliance findings and strong political support for securing domestic critical mineral supplies. The community is actively debating the stock's future, with many interpreting the current price volatility as a retail shakeout and positioning themselves for expected catalysts related to government funding and commercial recovery progress.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp (VST) is seeing significant investor attention following a major multi-gigawatt nuclear power purchase agreement with Meta, which is fueling excitement around the role of baseload energy in supporting long-term AI data center demand. While the stock has experienced volatility and recent pullbacks, the community is actively debating its valuation versus long-term growth potential, with many investors focusing on its strategic utility position in the PJM grid and the broader trend of hyperscalers securing reliable, carbon-free energy.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy Corp

Constellation Energy is experiencing significant volatility as investors weigh the stock's lofty valuations against recent regulatory news regarding potential power capacity auctions in the PJM grid region. While the long-term AI-driven data center power thesis remains a primary talking point for the community, sentiment is currently pressured by concerns over price caps, grid infrastructure bottlenecks, and uncertainty around future capacity auction profitability.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently in the spotlight as investors weigh its aggressive transition into an AI-driven robotics and autonomous driving company against near-term delivery headwinds. While the community is actively debating the company's long-term profitability and recent guidance, discussions remain divided between those viewing the current volatility as a strategic entry point and those concerned about macroeconomic and sector-wide pressures.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

Vor Biopharma is trending following major analyst endorsements, including an "Overweight" rating and a substantial price target from JPMorgan, coupled with a "Buy" rating from TD Cowen. The community is actively debating the significant upside potential, fueled by its lead autoimmune drug's recent Phase 3 clinical success and strategic financing, while also acknowledging its characteristic volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Defense, Biotech, and Aerospace Stories Dominate

Markets are opening Thursday with a mix of defense innovation, biotech progress, aerospace supply chain momentum, and turnaround earnings, highlighting how technology and strategic manufacturing continue to drive investor attention across several sectors. From next-generation biomaterials to counter-drone systems and aerospace electronics, the latest corporate developments suggest continued capital flow toward industries tied to national security, healthcare innovation, and advanced manufacturing. $KBLB, $IBO, $GXAI, $MOBX, $BTAI, $ALTO

<ul class="summary-bullets"><li>Under the revised agreement, the combined public company will issue around 169.6 million ordinary shares.</li><li>The combined public company will also issue 128,000 shares to DSS, its parent company.</li><li>This follows a June 2025 agreement to combine Dr Ashleys’ manufacturing with Impact BioMedical’s portfolio of more than 90 medical patents.</li></ul>Shares of Impact BioMedical (IBO) soared over 65% in pre-market trading on Thursday, after the company announced amendments to agreements tied to its planned merger with Dr Ashleys.If the pre-market level holds after the opening bell, <a href="https://stocktwits.com/symbol/IBO">IBO stock</a> would hit its highest since Sept. 12, 2025.<h2 class="st-heading-2">PubCo To Issue 169.6 Million Shares</h2>Under the revised agreement, the combined public company, referred to as PubCo, will issue 169,560,000 ordinary shares, which represent about 94.2% of PubCo’s outstanding shares at the closing of the business combination. These shares are called the Company Share Consideration.PubCo will issue 22,000 shares to Impact’s CEO, Frank D. Heuszel, and up to 128,000 shares to DSS in two batches. DSS is the parent company of Impact BioMedical. These shares will be&nbsp;deducted from the PubCo’s Company Share Consideration.Additionally, the deadline to complete the merger was extended from March 31, 2026, to July 1, 2026, while shareholders who support the transaction currently control about 88.9% of Impact BioMedical’s shares.<h2 class="st-heading-2">Merger To Open Up Manufacturing Access For Impact</h2>In June 2025, Impact BioMedical and Dr Ashleys signed a definitive merger agreement with Dr Ashleys. The transaction will create a new holding company that will own both Dr Ashleys and Impact BioMedical as subsidiaries. The combined company will be led by Dr Ashleys’ executive team and a newly appointed board.The merger aims to combine Dr Ashleys’ manufacturing and global market access with Impact BioMedical’s portfolio of more than 90 patents covering treatments for cancer, infectious diseases, respiratory illnesses, and orphan drugs.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>The stock garnered significant retail buzz, with Stocktwits data indicating a 14,200% increase in message volumes over the past 24 hours, while retail sentiment on the platform turned ‘extremely bullish’ from ‘bullish’ a day back.<img src="https://news.stocktwits-cdn.com/ibo_jpg_729ebe600c.webp" alt="ibo.jpg">One user sees a rally if the stock breaks over $0.8. It is currently at $0.69.<stembedurl>https://stocktwits.com/TroubleMaker/message/646636004</stembedurl>Another user sees the stock climbing to the $2.45 - $3 range.<stembedurl>https://stocktwits.com/Flybeast/message/646657749</stembedurl>Year-to-date, the stock has gained around 36%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-btai-stock-surge-in-pre-market-today/cZdQs29RI3E">Why Did BTAI Stock Surge 20% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did IBO Stock Surge 65% In Pre-Market Today?

The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026.

IBO Stock Spikes Pre-Market: Retail Traders Pile Into Biotech Penny Stock After Merger Update

Equity

Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.

IBO
Impact BioMedical Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest IBO News

IBOImpact BioMedical Inc.